US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 394.280
  • +0.800+0.20%
Close Apr 19 16:00 ET
  • 393.400
  • -0.880-0.22%
Post 18:06 ET
101.91BMarket Cap28.39P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
10.51%9.87B
9.34%2.52B
6.39%2.48B
13.52%2.49B
13.22%2.37B
17.91%8.93B
11.10%2.3B
17.65%2.33B
22.46%2.2B
21.64%2.1B
Operating revenue
10.51%9.87B
9.34%2.52B
6.39%2.48B
13.52%2.49B
13.22%2.37B
17.92%8.93B
11.10%2.3B
17.65%2.33B
22.46%2.2B
21.71%2.1B
Cost of revenue
16.84%1.26B
29.90%368M
10.12%318.7M
17.88%308.6M
8.58%266.9M
19.48%1.08B
14.51%283.3M
22.37%289.4M
14.82%261.8M
27.82%245.8M
Gross profit
9.64%8.61B
6.45%2.15B
5.86%2.16B
12.93%2.18B
13.84%2.11B
17.69%7.85B
10.64%2.02B
17.01%2.04B
23.57%1.93B
20.87%1.85B
Operating expense
23.37%4.3B
24.15%1.19B
20.41%1.07B
28.56%1.05B
20.51%983.7M
25.45%3.49B
16.83%961.5M
34.06%891.8M
26.75%815.4M
25.95%816.3M
Selling and administrative expenses
20.31%1.14B
38.03%369.1M
6.89%263.8M
21.97%262.6M
12.04%241.1M
12.45%944.7M
4.78%267.4M
24.52%246.8M
10.64%215.3M
12.02%215.2M
Research and development costs
24.51%3.16B
18.80%824.6M
25.58%810M
30.93%785.7M
23.54%742.6M
31.09%2.54B
22.24%694.1M
38.12%645M
33.74%600.1M
31.82%601.1M
Operating profit
-1.33%4.31B
-9.63%956M
-5.39%1.09B
1.55%1.14B
8.58%1.12B
12.15%4.37B
5.56%1.06B
6.53%1.15B
21.35%1.12B
17.14%1.04B
Net non-operating interest income expense
535.41%570.6M
127.02%168.9M
383.08%157M
3,613.16%133.5M
936.09%111.2M
258.66%89.8M
635.25%74.4M
330.50%32.5M
73.61%-3.8M
6.34%-13.3M
Non-operating interest income
325.10%614.7M
108.72%179.5M
263.42%167.9M
1,239.81%144.7M
7,562.50%122.6M
2,851.02%144.6M
7,066.67%86M
4,100.00%46.2M
881.82%10.8M
6.67%1.6M
Non-operating interest expense
-19.53%44.1M
-8.62%10.6M
-20.44%10.9M
-23.29%11.2M
-23.49%11.4M
-10.89%54.8M
-23.18%11.6M
-9.87%13.7M
-5.81%14.6M
-5.10%14.9M
Other net income (expense)
-123.65%-498.3M
140.90%22.7M
-647.83%-68.8M
-19.27%-108.3M
-411.00%-343.9M
79.84%-222.8M
52.73%-55.5M
-163.45%-9.2M
90.46%-90.8M
-37.91%-67.3M
Special income (charges)
-719.83%-475.5M
233.20%32.5M
-100.38%-52.9M
-765.35%-109.9M
-6,376.36%-345.2M
94.78%-58M
80.40%-24.4M
5.38%-26.4M
98.68%-12.7M
41.03%5.5M
-Less：Restructuring and merger&acquisition
10.26%-51.6M
-2,894.44%-50.3M
146.15%1.2M
98.78%-600K
74.67%-1.9M
-1,754.84%-57.5M
190.00%1.8M
-316.67%-2.6M
-3,175.00%-49.2M
-92.31%-7.5M
-Less:Other special charges
356.36%527.1M
-21.24%17.8M
78.28%51.7M
78.51%110.5M
17,255.00%347.1M
-89.63%115.5M
-82.13%22.6M
8.61%29M
-93.54%61.9M
--2M
Other non- operating income (expenses)
86.17%-22.8M
68.49%-9.8M
-192.44%-15.9M
102.05%1.6M
101.79%1.3M
-3,463.27%-164.8M
-538.03%-31.1M
-59.43%17.2M
-1,064.20%-78.1M
-38.14%-72.8M
Income before tax
3.48%4.38B
6.58%1.15B
0.24%1.18B
13.38%1.16B
-6.63%891.5M
55.01%4.23B
23.64%1.08B
8.64%1.18B
2,417.65%1.02B
16.31%954.8M
Income tax
-16.50%760.2M
-30.67%178.8M
-41.48%143.9M
14.91%245.8M
-0.52%191.7M
134.46%910.4M
155.85%257.9M
6.50%245.9M
292.36%213.9M
14.84%192.7M
Net income
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
41.84%3.32B
6.34%818.9M
9.23%930.5M
1,109.70%810.5M
16.69%762.1M
Net income continuous Operations
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
41.84%3.32B
6.34%818.9M
9.23%930.5M
1,109.70%810.5M
16.69%762.1M
Minority interest income
Net income attributable to the parent company
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
41.84%3.32B
6.34%818.9M
9.23%930.5M
1,109.70%810.5M
16.69%762.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
41.84%3.32B
6.34%818.9M
9.23%930.5M
1,109.70%810.5M
16.69%762.1M
Basic earnings per share
8.33%14.05
17.87%3.76
10.47%4.01
11.99%3.55
-9.03%2.72
42.68%12.97
5.63%3.19
10.00%3.63
1,119.23%3.17
18.65%2.99
Diluted earnings per share
8.35%13.89
17.78%3.71
10.58%3.97
12.46%3.52
-9.12%2.69
42.29%12.82
5.00%3.15
9.45%3.59
1,103.85%3.13
18.88%2.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 10.51%9.87B9.34%2.52B6.39%2.48B13.52%2.49B13.22%2.37B17.91%8.93B11.10%2.3B17.65%2.33B22.46%2.2B21.64%2.1B
Operating revenue 10.51%9.87B9.34%2.52B6.39%2.48B13.52%2.49B13.22%2.37B17.92%8.93B11.10%2.3B17.65%2.33B22.46%2.2B21.71%2.1B
Cost of revenue 16.84%1.26B29.90%368M10.12%318.7M17.88%308.6M8.58%266.9M19.48%1.08B14.51%283.3M22.37%289.4M14.82%261.8M27.82%245.8M
Gross profit 9.64%8.61B6.45%2.15B5.86%2.16B12.93%2.18B13.84%2.11B17.69%7.85B10.64%2.02B17.01%2.04B23.57%1.93B20.87%1.85B
Operating expense 23.37%4.3B24.15%1.19B20.41%1.07B28.56%1.05B20.51%983.7M25.45%3.49B16.83%961.5M34.06%891.8M26.75%815.4M25.95%816.3M
Selling and administrative expenses 20.31%1.14B38.03%369.1M6.89%263.8M21.97%262.6M12.04%241.1M12.45%944.7M4.78%267.4M24.52%246.8M10.64%215.3M12.02%215.2M
Research and development costs 24.51%3.16B18.80%824.6M25.58%810M30.93%785.7M23.54%742.6M31.09%2.54B22.24%694.1M38.12%645M33.74%600.1M31.82%601.1M
Operating profit -1.33%4.31B-9.63%956M-5.39%1.09B1.55%1.14B8.58%1.12B12.15%4.37B5.56%1.06B6.53%1.15B21.35%1.12B17.14%1.04B
Net non-operating interest income expense 535.41%570.6M127.02%168.9M383.08%157M3,613.16%133.5M936.09%111.2M258.66%89.8M635.25%74.4M330.50%32.5M73.61%-3.8M6.34%-13.3M
Non-operating interest income 325.10%614.7M108.72%179.5M263.42%167.9M1,239.81%144.7M7,562.50%122.6M2,851.02%144.6M7,066.67%86M4,100.00%46.2M881.82%10.8M6.67%1.6M
Non-operating interest expense -19.53%44.1M-8.62%10.6M-20.44%10.9M-23.29%11.2M-23.49%11.4M-10.89%54.8M-23.18%11.6M-9.87%13.7M-5.81%14.6M-5.10%14.9M
Other net income (expense) -123.65%-498.3M140.90%22.7M-647.83%-68.8M-19.27%-108.3M-411.00%-343.9M79.84%-222.8M52.73%-55.5M-163.45%-9.2M90.46%-90.8M-37.91%-67.3M
Special income (charges) -719.83%-475.5M233.20%32.5M-100.38%-52.9M-765.35%-109.9M-6,376.36%-345.2M94.78%-58M80.40%-24.4M5.38%-26.4M98.68%-12.7M41.03%5.5M
-Less：Restructuring and merger&acquisition 10.26%-51.6M-2,894.44%-50.3M146.15%1.2M98.78%-600K74.67%-1.9M-1,754.84%-57.5M190.00%1.8M-316.67%-2.6M-3,175.00%-49.2M-92.31%-7.5M
-Less:Other special charges 356.36%527.1M-21.24%17.8M78.28%51.7M78.51%110.5M17,255.00%347.1M-89.63%115.5M-82.13%22.6M8.61%29M-93.54%61.9M--2M
Other non- operating income (expenses) 86.17%-22.8M68.49%-9.8M-192.44%-15.9M102.05%1.6M101.79%1.3M-3,463.27%-164.8M-538.03%-31.1M-59.43%17.2M-1,064.20%-78.1M-38.14%-72.8M
Income before tax 3.48%4.38B6.58%1.15B0.24%1.18B13.38%1.16B-6.63%891.5M55.01%4.23B23.64%1.08B8.64%1.18B2,417.65%1.02B16.31%954.8M
Income tax -16.50%760.2M-30.67%178.8M-41.48%143.9M14.91%245.8M-0.52%191.7M134.46%910.4M155.85%257.9M6.50%245.9M292.36%213.9M14.84%192.7M
Net income 8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M41.84%3.32B6.34%818.9M9.23%930.5M1,109.70%810.5M16.69%762.1M
Net income continuous Operations 8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M41.84%3.32B6.34%818.9M9.23%930.5M1,109.70%810.5M16.69%762.1M
Minority interest income
Net income attributable to the parent company 8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M41.84%3.32B6.34%818.9M9.23%930.5M1,109.70%810.5M16.69%762.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M41.84%3.32B6.34%818.9M9.23%930.5M1,109.70%810.5M16.69%762.1M
Basic earnings per share 8.33%14.0517.87%3.7610.47%4.0111.99%3.55-9.03%2.7242.68%12.975.63%3.1910.00%3.631,119.23%3.1718.65%2.99
Diluted earnings per share 8.35%13.8917.78%3.7110.58%3.9712.46%3.52-9.12%2.6942.29%12.825.00%3.159.45%3.591,103.85%3.1318.88%2.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.13%